Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01842165Phase 3Completed
177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
Gastroenteropancreatic Neuroendocrine Tumors
Studychair

Research Network

Collaboration Network

6 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Jules Bordet Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

9 similar investigators found

Urielle Desalbres

AP-HM

Moderately Similar
8 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors
Similarity Score30%

Christoph Stettler, Prof. Dr. med.

Division of Endocrinology, University Hospital Bern

Moderately Similar
1 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors
Similarity Score30%

Simron Singh, MD, MPH

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors
Similarity Score30%

Giovanni Paganelli, MD

IRST IRCCS, Meldola (FC)

Moderately Similar
2 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors
Similarity Score30%

Weibing Miao, MD

First Affiliated Hospital of Fujian Medical University

Moderately Similar
12 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors
Similarity Score30%

Thomas Krause, Prof. Dr. med.

Institute of Nuclear Medicine, University Hospital Berne

Moderately Similar
1 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors
Similarity Score30%

Alain Hendlisz, MD

Jules Bordet Institute

Related
6 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score14%

Amélie Deleporte, MD

Jules Bordet Institute

Related
1 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score14%

Patrick Flamen, M.D., Ph.D.

Jules Bordet Institute

Related
2 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01842165Phase 3StudyChair

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs

Gastroenteropancreatic Neuroendocrine Tumors
Completed

All 1 trials loaded